封面
市場調查報告書
商品編碼
1513771

全球心房顫動設備市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Atrial Fibrillation Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

全球心房顫動設備市場需求預計將從 2023 年的 109.6 億美元達到 2032 年近 376.2 億美元的市場規模,2024-2032 年研究期間複合年成長率為 14.69%。

心房顫動 (AF) 設備是用於管理和治療心房顫動的專用醫療設備,心房顫動是一種常見的心律不整,其特徵是心率不規則且通常較快。心房顫動設備包括心律調節器、植入式心律轉復除顫器 (ICD) 和導管消融系統。心律調節器透過向心臟發送電脈衝來幫助調節心律,而 ICD 可以透過提供電擊來檢測和糾正異常心律。導管消融涉及使用能量破壞導致 AF 的心臟組織小區域。這些設備透過減少心房顫動患者的症狀、預防併發症和提高生活品質,顯著改善患者的治療效果。

市場動態

由於心房顫動 (AF) 盛行率不斷上升,特別是在老齡化人口中,心房顫動設備市場正在經歷強勁成長,導致對有效管理解決方案的需求更高。醫療技術的進步也發揮了關鍵作用,促進了創新型心房顫動設備的開發,提高了準確性、安全性和患者治療效果。這些技術進步包括下一代心律調節器、導管消融系統和植入式心律轉復除顫器 (ICD),顯著增強了 AF 治療。此外,人們對未經治療的心房顫動(如中風和心臟衰竭)相關風險的認知不斷提高,鼓勵更多患者尋求治療,從而促進市場成長。此外,支持性政府政策和增加的醫療保健支出有助於更好地獲得先進的心房顫動治療選擇。然而,心房顫動設備的高成本以及發展中地區獲得先進醫療保健的機會有限可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球心房顫動設備市場的各個細分市場進行了包容性評估。心房顫動設備產業的成長和趨勢為本研究提供了整體方法。

市場區隔

心房顫動設備市場報告的這一部分提供了國家和地區層面細分市場的詳細資料,從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

  • EP消融導管
  • EP 診斷導管
  • 測繪和記錄系統
  • 心臟監測儀或植入式循環記錄儀
  • 存取裝置
  • 心內超音波心動圖(ICE)
  • 左心耳 (LAA) 封堵器

按最終用途

  • 醫院
  • 心臟中心
  • 門診手術中心
  • 其他

區域分析

本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的心房顫動設備市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。心房顫動設備市場的主要參與者包括雅培實驗室、強生公司、Atricure Inc.、Microport Scientific Corporation、Boston Scientific Corporation、St. Jude Medical Inc、Medtronic Plc、Koninklijke Philips NV、Siemens AG。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章:前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章:執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章:心房顫動設備 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析:按地區

第 4 章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章:全球心房顫動設備市場分析:依產品分類

  • 概述(按產品)
  • 按產品分類的歷史和預測資料分析
  • EP消融導管
  • EP 診斷導管
  • 測繪和記錄系統
  • 心臟監測儀或植入式循環記錄儀
  • 存取裝置
  • 心內超音波心動圖(ICE)
  • 左心耳 (LAA) 封堵器

第 6 章:全球心房顫動設備市場分析:依最終用途分類

  • 按最終用途分類的概述
  • 按最終用途分類的歷史和預測資料分析
  • 醫院
  • 心臟中心
  • 門診手術中心
  • 其他

第 7 章:全球心房顫動設備市場分析:依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 8 章:心房顫動設備公司的競爭格局

  • 心房顫動設備市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 9 章:公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Abbott Laboratories
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Johnson & Johnson
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Atricure Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Microport Scientific Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Boston Scientific Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • St. Jude Medical Inc
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Medtronic Plc
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Koninklijke Philips NV
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Siemens AG
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

註 - 在公司概況中,財務詳細資料和最新進展視情況而定,或對私人公司而言可能不包括在內

Product Code: VMR112115079

The global demand for Atrial Fibrillation Devices Market is presumed to reach the market size of nearly USD 37.62 Billion by 2032 from USD 10.96 Billion in 2023 with a CAGR of 14.69% under the study period 2024-2032.

Atrial fibrillation (AF) devices are specialized medical devices used to manage and treat atrial fibrillation, a common cardiac arrhythmia characterized by irregular and often rapid heart rate. Atrial fibrillation devices include pacemakers, implantable cardioverter defibrillators (ICDs), and catheter ablation systems. Pacemakers help regulate heart rhythms by sending electrical impulses to the heart, while ICDs can detect and correct abnormal rhythms by delivering shocks. Catheter ablation involves using energy to destroy small areas of heart tissue that cause AF. These devices significantly improve patient outcomes by reducing symptoms, preventing complications, and enhancing the quality of life for those with atrial fibrillation.

MARKET DYNAMICS

The atrial fibrillation devices market is experiencing robust growth fuelled by the rising prevalence of atrial fibrillation (AF), particularly among the aging population, leading to a higher demand for effective management solutions. Progress in medical technology has also had a pivotal role, resulting in the development of innovative atrial fibrillation devices that offer improved accuracy, safety, and patient outcomes. These technological advancements include next-generation pacemakers, catheter ablation systems, and implantable cardioverter defibrillators (ICDs), significantly enhancing AF treatment. Furthermore, the rising awareness about the risks associated with untreated atrial fibrillation, such as stroke and heart failure, is encouraging more patients to seek treatment, thereby boosting market growth. Additionally, supportive government policies and increasing healthcare expenditure facilitate better access to advanced AF treatment options. However, the high cost of atrial fibrillation devices and limited access to advanced healthcare in developing regions may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Atrial Fibrillation Devices. The growth and trends of Atrial Fibrillation Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Atrial Fibrillation Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • EP Ablation Catheters
  • EP Diagnostic Catheters
  • Mapping and Recording Systems
  • Cardiac Monitors or Implantable Loop Recorder
  • Access Devices
  • Intracardiac Echocardiography (ICE)
  • Left Atrial Appendage (LAA) Closure Devices

By End-use

  • Hospitals
  • Cardiac Centers
  • Ambulatory Surgical Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Atrial Fibrillation Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Atrial Fibrillation Devices market include Abbott Laboratories, Johnson & Johnson, Atricure Inc., Microport Scientific Corporation, Boston Scientific Corporation, St. Jude Medical Inc, Medtronic Plc, Koninklijke Philips N.V., Siemens AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ATRIAL FIBRILLATION DEVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By End-use
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. EP Ablation Catheters Historic and Forecast Sales By Regions
  • 5.4. EP Diagnostic Catheters Historic and Forecast Sales By Regions
  • 5.5. Mapping and Recording Systems Historic and Forecast Sales By Regions
  • 5.6. Cardiac Monitors or Implantable Loop Recorder Historic and Forecast Sales By Regions
  • 5.7. Access Devices Historic and Forecast Sales By Regions
  • 5.8. Intracardiac Echocardiography (ICE) Historic and Forecast Sales By Regions
  • 5.9. Left Atrial Appendage (LAA) Closure Devices Historic and Forecast Sales By Regions

6. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET ANALYSIS BY END-USE

  • 6.1. Overview By End-use
  • 6.2. Historical and Forecast Data Analysis By End-use
  • 6.3. Hospitals Historic and Forecast Sales By Regions
  • 6.4. Cardiac Centers Historic and Forecast Sales By Regions
  • 6.5. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE ATRIAL FIBRILLATION DEVICES COMPANIES

  • 8.1. Atrial Fibrillation Devices Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF ATRIAL FIBRILLATION DEVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Abbott Laboratories
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Johnson & Johnson
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Atricure Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Microport Scientific Corporation
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Boston Scientific Corporation
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. St. Jude Medical Inc
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Medtronic Plc
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Koninklijke Philips N.V.
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Siemens AG
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • EP Ablation Catheters Market Sales By Geography (USD MN)
  • EP Diagnostic Catheters Market Sales By Geography (USD MN)
  • Mapping and Recording Systems Market Sales By Geography (USD MN)
  • Cardiac Monitors or Implantable Loop Recorder Market Sales By Geography (USD MN)
  • Access Devices Market Sales By Geography (USD MN)
  • Intracardiac Echocardiography (ICE) Market Sales By Geography (USD MN)
  • Left Atrial Appendage (LAA) Closure Devices Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Cardiac Centers Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Atrial Fibrillation Devices Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Atrial Fibrillation Devices Report
  • Market Research Process
  • Market Research Methodology
  • Global Atrial Fibrillation Devices Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • EP Ablation Catheters Market Sales By Geography (USD MN)
  • EP Diagnostic Catheters Market Sales By Geography (USD MN)
  • Mapping and Recording Systems Market Sales By Geography (USD MN)
  • Cardiac Monitors or Implantable Loop Recorder Market Sales By Geography (USD MN)
  • Access Devices Market Sales By Geography (USD MN)
  • Intracardiac Echocardiography (ICE) Market Sales By Geography (USD MN)
  • Left Atrial Appendage (LAA) Closure Devices Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Cardiac Centers Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.